- Home
- ABSI vs PRQR Comparison
ABSI vs PRQR Comparison
Compare ABSI & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABSI
- PRQR
- Stock Information
- Founded
- ABSI 2011
- PRQR 2012
- Country
- ABSI United States
- PRQR Netherlands
- Employees
- ABSI N/A
- PRQR N/A
- Industry
- ABSI Biotechnology: Pharmaceutical Preparations
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- ABSI Health Care
- PRQR Health Care
- Exchange
- ABSI Nasdaq
- PRQR Nasdaq
- Market Cap
- ABSI 353.8M
- PRQR 309.5M
- IPO Year
- ABSI 2021
- PRQR 2014
- Fundamental
- Price
- ABSI $3.01
- PRQR $1.65
- Analyst Decision
- ABSI Strong Buy
- PRQR Strong Buy
- Analyst Count
- ABSI 6
- PRQR 6
- Target Price
- ABSI $7.83
- PRQR $8.50
- AVG Volume (30 Days)
- ABSI 4.4M
- PRQR 448.8K
- Earning Date
- ABSI 03-18-2025
- PRQR 03-13-2025
- Dividend Yield
- ABSI N/A
- PRQR N/A
- EPS Growth
- ABSI N/A
- PRQR N/A
- EPS
- ABSI N/A
- PRQR N/A
- Revenue
- ABSI $4,534,000.00
- PRQR $20,235,014.00
- Revenue This Year
- ABSI $257.06
- PRQR $39.44
- Revenue Next Year
- ABSI $112.29
- PRQR N/A
- P/E Ratio
- ABSI N/A
- PRQR N/A
- Revenue Growth
- ABSI N/A
- PRQR 196.41
- 52 Week Low
- ABSI $2.45
- PRQR $1.59
- 52 Week High
- ABSI $6.72
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- ABSI 38.78
- PRQR 28.26
- Support Level
- ABSI $2.81
- PRQR $1.78
- Resistance Level
- ABSI $3.15
- PRQR $1.87
- Average True Range (ATR)
- ABSI 0.23
- PRQR 0.11
- MACD
- ABSI -0.02
- PRQR -0.02
- Stochastic Oscillator
- ABSI 33.61
- PRQR 10.53
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.